Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

China Pharma Holdings, Inc. to Report Fiscal Year 2010 Financial Results on March 3, 2011

February 25, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

HAIKOU, China, Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI ), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its fiscal year 2010 financial...

Gen-Probe to Webcast Three Upcoming Investor Presentations

February 25, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 24, 2011 /- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company will present at three upcoming investor conferences: RBC Capital Markets' Healthcare Conference in New York at 10 a.m. Eastern Time (ET) on March 2.  The Company also will participate...

Reportlinker Adds Global ECG Telemetry Devices Industry

February 24, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global ECG Telemetry Devices Industry http://www.reportlinker.com/p090653/Global-ECG-Telemetry-Devices-Industry.html This report analyzes the worldwide markets for ECG...

Advertisement

Reportlinker Adds Global Cardiac Defibrillators Industry

February 24, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Cardiac Defibrillators Industry http://www.reportlinker.com/p098394/Global-Cardiac-Defibrillators-Industry.html This report analyzes the worldwide markets for...

Reportlinker Adds Global Special Purpose Needles Industry

February 24, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Special Purpose Needles Industry http://www.reportlinker.com/p098381/Global-Special-Purpose-Needles-Industry.html This report analyzes the worldwide markets for...

Reportlinker Adds Global Drug-Eluting Stents Industry

February 24, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Drug-Eluting Stents Industry http://www.reportlinker.com/p080457/Global-Drug-Eluting-Stents-Industry.html This report analyzes the worldwide markets for...

American Medical Systems Announces U.S. Launch of Concealâ„¢ Low Profile Reservoir for Penile Prosthetics

February 24, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

MINNETONKA, Minn., Feb. 24, 2011 /- American Medical Systems® (AMS) (Nasdaq: AMMD ), a leading provider of world-class devices and therapies for male and female pelvic health, today announced the full U.S. launch of its new Conceal™ Low Profile Reservoir, an enhancement to the...

HeartWare International Reports Fourth Quarter 2010 Revenues of $20.9 Million; 71% Increase From $12.2 Million In Fourth Quarter 2009

February 24, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass. and SYDNEY, Feb. 24, 2011 /- HeartWare International, Inc. (Nasdaq: HTWR ; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenues of $20.9...

Advertisement

Royal Fornia Electronic Device Co., Ltd. Signs Technology Licensing Agreement to Integrate Masimo rainbow SET Pulse CO-Oximetry Into New Patient Monitors

February 24, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif. and GUANGDONG PROVINCE, China, Feb. 24, 2011 /- Masimo (Nasdaq: MASI ) and Royal Fornia Electronic Device Co., Ltd. jointly announce a worldwide technology licensing agreement to integrate Masimo rainbow SET® Pulse CO-Oximetry™ technology into Royal Fornia's new...

NewCardio Study Shows CardioBip Detects Recurrent Atrial Fibrillation Earlier and More Reliably than Periodic Holter Monitoring(2)

February 24, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., Feb. 24, 2011 /- PR Newswire – NewCardio, Inc., (OTC Bulletin Board: NWCI ) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited by the Heart Rhythm Society (HRS) to present results of a recent clinical study showing...

Support the Have a HeArt Benefit, Feb. 25

February 23, 2011 12:35 pm | by Arizona State University | News | Comments

ASU's College of Nursing & Health Innovation is hosting a "Have a HeART Benefit," Feb. 25, with proceeds going to the College's NP Healthcare Clinics.read more

Dave Anderson and William Thomsen Join SRI International's Center for Advanced Drug Research to Lead Programs in Proteomics and Metabolic Disease Drug Discovery

February 23, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

MENLO PARK, Calif., Feb. 23, 2011 /- SRI International, an independent nonprofit research and development organization, announced today that two new principal scientists, Dave Anderson, Ph.D., and William Thomsen, Ph.D., have joined its Center for Advanced Drug Research (CADRE) in...

Novo Nordisk Submits First Recombinant Treatment for Factor XIII Deficiency for U.S. Regulatory Approval

February 23, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Feb. 23, 2011 /- Novo Nordisk announced today that a Biologic License Application (BLA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting the approval of a recombinant factor XIII compound (rFXIII) for the vast majority of patients with...

Advertisement

Regeneron Announces March 2011 Investor Conference Presentations

February 23, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., Feb. 23, 2011 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast management presentations at the following investor conferences: Citi 2011 Global Healthcare Conference at 9:00 a.m. Eastern Time on Tuesday, March 1, 2011 RBC Capital Markets' 2011 Healthcare...

Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City

February 23, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

BASKING RIDGE, N.J., Feb. 23, 2011 /- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be speaking and participating on a...

Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts

February 23, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., Feb. 23, 2011 /- Xenogenics Corporation ("Xenogenics"), a majority owned subsidiary of MultiCell Technologies, Inc. (OTC Bulletin Board MCET), is pleased to announce it has retained the Emmes Group to assist with the development and execution of its capital formation...

Abaxis, Inc. to Present at RBC Capital Markets' Healthcare Conference

February 23, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., Feb. 23, 2011 /- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at the RBC Capital Markets' Healthcare Conference on...

Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study

February 23, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Feb. 23, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today the results from a Phase 1 clinical trial in which ISIS-CRPRx produced statistically significant reductions in C-reactive protein (CRP) in the cohort of subjects in the study with elevated CRP....

Reportlinker Adds Global Medical Ultrasound Equipment Industry

February 23, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Feb. 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Medical Ultrasound Equipment Industry http://www.reportlinker.com/p098401/Global-Medical-Ultrasound-Equipment-Industry.html This report analyzes the worldwide...

Published Data From e-HEALING Registry Demonstrate Good Clinical Outcomes With Low Incidence of Repeat Revascularization and Stent Thrombosis for OrbusNeich's Genousâ„¢ Stent

February 22, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

HONG KONG, Feb. 22, 2011 /- OrbusNeich today announced that 12-month follow-up data from the e-HEALING ( H ealthy E ndothelial A ccelerated L ining I nhibits N eointimal G rowth) registry published in the February issue of EuroIntervention demonstrated good clinical outcomes with low...

Seal Shield Introduces iPad Keyboard and Case for Healthcare

February 21, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla., Feb. 21, 2011 /- Seal Shield LLC today announced the new SILVER BLUE™ Bluetooth wireless keyboard and case for the iPad.  The product has been designed specifically for healthcare and addresses infection control concerns over iPad use in hospital settings. The...

LifeWatch Teams With UnitedHealthcare, The Largest Healthcare Insurer In The United States, As A Preferred National Provider Of Cardiac Monitoring Services To Reduce Patient C...

February 20, 2011 10:34 pm | by Bio-Medicine.Org | News | Comments

ROSEMONT, Ill., Feb. 21, 2011 /- LifeWatch AG (SIX Swiss Exchange: LIFE) today announces an initiative with UnitedHealthcare Insurance Company, an affiliate of United-Health Group (NYSE: UNH) that will provide members insured by UnitedHealthcare in-network access to LifeWatch cardiac...

Penn Doctors Certified in New Advanced Heart Failure and Transplant Cardiology Specialty

February 18, 2011 6:33 am | by University Of Pennsylvania | News | Comments

Penn Medicine cardiologists are leaders in a new cardiology subspecialty, Advanced Heart Failure and Transplant Cardiology. Seven of the nine Heart Failure and Transplant doctors at Penn are now certified by the American Board of Internal Medicine (ABIM) in the new Advanced Heart Failure...

Boston Scientific Launches PROMUS® Elementâ„¢ and TAXUS® Elementâ„¢ Stent Systems in India

February 18, 2011 3:36 am | by Boston Scientific | News | Comments

Company's third-generation drug-eluting stents now available in rapidly growing market

MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors

February 18, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Feb. 18, 2011 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced the appointment of Scott R. Ward as Chairman of its Board of Directors. Steven A. Elms, the incumbent Chairman and an original venture capital investor in the Company, will step down from the...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading